22 reports

  • RECKITT BENCKISER (US COUGH AND COLD OTC DRUG SALES) - FINANCIAL PERFORMANCE*
  • INDUSTRY DEFINITION

High capital intensity is more than $##. ## of capital to $## of labor; medium is $##. ## to $##. ## of capital to $## of labor; low is less than $##. ## of capital for every $## of labor.

  • Cough And Cold
  • OTC
  • United States
  • Demand

The 2020-2025 World Outlook for Combination Cough-Cold-Allergy Medicines ## INTRODUCTION ##. ## OVERVIEW ##. ## WHAT IS LATENT DEMAND AND THE P. I. E.?

  • Cough And Cold
  • OTC
  • World
  • Demand

The 2019-2024 Outlook for Combination Cough-Cold-Allergy Medicines in China ## INTRODUCTION ##. ## OVERVIEW ##. ## WHAT IS LATENT DEMAND AND THE P. I. E.?

  • Cough And Cold
  • OTC
  • China
  • Demand

The 2019-2024 Outlook for Combination Cough-Cold-Allergy Medicines in the United States ## INTRODUCTION ##. ## OVERVIEW ##. ## WHAT IS LATENT DEMAND AND THE P. I. E.?

  • Cough And Cold
  • OTC
  • United States
  • Demand

The 2019-2024 Outlook for Combination Cough-Cold-Allergy Medicines in India ## INTRODUCTION ##. ## OVERVIEW ##. ## WHAT IS LATENT DEMAND AND THE P. I. E.?

  • Cough And Cold
  • OTC
  • India
  • Demand
  • Cough and Cold Medicine
  • Cough and Cold Medicine Export and Market Share (billion

Page## RESPIRATORY DRUGS PRODUCTION AND DEMAND (billion Yuan/ percent) Chart ##: Cough and Cold Medicine Sales Volume and Market Share Chapter I V ##.

  • Cough And Cold
  • China
  • Demand
  • Market Size
  • Trade
  • Cough and Cold Medicine
  • Cough and Cold Medicine Producers

Page## RESPIRATORY DRUGS PRODUCTION AND DEMAND (billion Yuan/ percent) Chart ##: Cough and Cold Medicine Sales Volume and Market Share Chapter I V ##.

  • Cough And Cold
  • China
  • Demand
  • Market Size
  • GlaxoSmithKline plc

Cough/ Cold Remedies - Market Trends & Insights ##.

  • Cough And Cold
  • OTC
  • United States
  • Demand
  • Market Shares

This influence varies from one industry to another, but also from one period of time to another.

  • Cough And Cold
  • OTC
  • Pharmaceutical
  • Demand

This influence varies from one industry to another, but also from one period of time to another.

  • Cough And Cold
  • OTC
  • Pharmaceutical
  • China
  • Demand

This influence varies from one industry to another, but also from one period of time to another.

  • Cough And Cold
  • OTC
  • Pharmaceutical
  • United States
  • Demand

This influence varies from one industry to another, but also from one period of time to another.

  • Cough And Cold
  • OTC
  • Pharmaceutical
  • India
  • Demand
  • Sales Per Capita of Select CCA Products and Y-o-Y % Growth of CCA Category 2011-2016
  • What do consumers take when they get sick?

Generally, among flu-related medicines, US consumers spend the most per capita on combination cough, cold and allergy products.

  • Cough And Cold
  • Influenza
  • United States
  • Demand
  • Mondelez International, Inc.

(India) ##.

  • Cough And Cold
  • Australasia
  • United States
  • World
  • Market Shares
  • Allergy, Cough, Cold, and Sinus Products
  • Three: Allergy, Cough, Cold, and Sinus Products

Chapter Three: Allergy, Cough, Cold, and Sinus Products Figure ##-## U. S.

  • Cough And Cold
  • United States
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Jul 13, 2017: WEIFA: Record Second-Quarter Revenues Driven By Pain And Cough & Cold
  • Aqualis Completes Rights Offering Of Shares For US$9 Million

The organic growth was driven by increased demand for pain and cough and cold products.

  • Cough And Cold
  • Norway
  • Company Financials
  • M&A
  • Weifa
  • Mechanism Of Action R&D Progress
  • Nasopharyngitis (Common Cold) - Product Development Milestones

Chlorpheniramine is one of the most widely used anti-histamines to manage cough and cold co-symptoms.

  • Cough And Cold
  • United States
  • World
  • Company Sales
  • Product Initiative
  • Nasopharyngitis (Common Cold) - Product Development Milestones
  • Regulatory Details

Chlorpheniramine is one of the most widely used anti-histamines to manage cough and cold co-symptoms.

  • Cough And Cold
  • Pharmaceutical
  • Respiratory Disease
  • United States
  • Product Initiative
  • Jul 18, 2017: Vernalis: Year-End Trading Update and Notice of Full Year Results
  • EQUITY OFFERING

One of the Phase IIa studies was in Cystic Fibrosis patients with statistically significant increases in average forced expiratory volume in one second.

  • Cough And Cold
  • Pharmaceutical
  • Therapy
  • United States
  • Vernalis plc

The prominent features of this report are - ##.

  • Cough And Cold
  • Respiratory Disease
  • Therapy
  • World
  • Product Initiative
  • Alfa Intes Enters into Licensing Agreement with Bitop for Ectoin Allergy Nasal Spray
  • Vifor Pharma Enters into Licensing Agreement with Bitop for Ectoin Allergy Eye Drops and Ectoin Allergy Nasal Sprays

It offers medical devices for dermatology, allergy, cough and cold; airway diseases and dry epithelia applications.

  • Cough And Cold
  • Medical Equipment
  • Medical Supply
  • United States
  • Deals & Alliance
  • LICENSING AGREEMENTS

It offers medical devices for dermatology, allergy, cough and cold; airway diseases and dry epithelia applications.

  • Cough And Cold
  • Pharmaceutical
  • United States
  • Company
  • Deals & Alliance